Given that the subsidies in the federal exchange have helped to cover a lot of previously uninsured people, Chip Kahn, president and chief executive officer of the Federation of American Hospitals, remains encouraged the Supreme Court will "do the right thing."
Given that the subsidies in the federal exchange have helped to cover a lot of previously uninsured people, Chip Kahn, president and chief executive officer of the Federation of American Hospitals, who had been in attendance at the Supreme Court for oral arguments on King v. Burwell on March 4, 2015, remains encouraged the Supreme Court will "do the right thing."
He is bullish that the Court will rule in favor of the government, and as such has not put too much thought into what plans will need to be made in the event that the ruling is in favor of the plaintiffs.
"It's just hard for me to imagine that interpretation over a few words in drafting are going to result in 8.8 million potentially losing their health insurance coverage," Mr Kahn said.
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer
December 9th 2023This phase 3 study investigated sacituzumab govitecan, a Trop-2–directed antibody-drug conjugate, vs treatment of physician’s choice in pretreated patients who have endocrine-resistant hormone receptor–positive/HER2-negative breast cancer, the most common form of breast cancer.
Read More
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More